Chronic myeloid leukaemia and sickle cell disease: could imatinib prevent vaso-occlusive crisis?

Br J Haematol. 2011 Oct;155(2):271-2. doi: 10.1111/j.1365-2141.2011.08670.x. Epub 2011 Apr 13.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anemia, Sickle Cell / complications*
  • Antineoplastic Agents / therapeutic use*
  • Arterial Occlusive Diseases / etiology
  • Arterial Occlusive Diseases / prevention & control*
  • Benzamides
  • Follow-Up Studies
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
  • Patient Compliance
  • Piperazines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Recurrence

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate